Stepan Q4 adj. EPS $0.12, down 64%; full-year adj. EBITDA up 4%, Polymers weak

STEPAN CO

2024-FY EPS reported $2.20 revenue$2,180,274,000

Q4 reported net income $3.4M vs prior-year loss of $1.2M; adjusted net income $2.8M (-63%).
Full-year adj. EBITDA $187.0M (+4%); free cash flow $39.3M vs -$85.5M in 2023.
Surfactants adj. EBITDA +10% in Q4; Polymers adj. EBITDA -44% on 9% volume decline.
Pasadena alkoxylation facility expected to start in Q1 2025; quarterly dividend $0.385/sh, payable March 14.
Cost-out savings of $48M in 2024; full-year effective tax rate 16.7% vs 16.9%.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.